勃起不全治療薬の世界市場レポート2024

勃起不全治療薬の市場規模は、今後数年間で若干の成長が見込まれると予想されます。 2028年には1.7%の年間複合成長率（CAGR）で44億6,000万米ドルに成長すると予想されます。予測される成長は、メンタルヘルスの統合、消費者の嗜好の変化、新興市場の拡大、再生医療の探求、バイオ医薬品のイノベーションによって推進されます。主な動向には、新しい治療法の開発、意識の高まり、ライフスタイルの変化、遠隔医療、革新的な送達システムなどが含まれます。

慢性疾患の数の大幅な増加が、勃起不全治療薬市場の主要な促進要因となっています。勃起不全は主に、心臓血管疾患、糖尿病、肥満、高血圧など、座りっぱなしのライフスタイルに起因する慢性疾患に関連しています。 2023年 9月に世界保健機関（WHO）が報告したように、慢性疾患が原因で年間4,100万人が死亡しており、世界全体の死亡者数の74%を占めています。慢性疾患の蔓延により、男性の勃起不全の可能性が高まり、その結果、勃起不全治療薬の市場が拡大しています。

高血圧症の有病率の増加は、予見可能な将来において勃起不全治療薬市場の成長を促進すると予想されます。高血圧は、動脈壁に対する持続的な高い血圧を特徴とし、一般的な病状です。シルデナフィルなどの勃起不全治療薬は、血管機能を改善し、血圧を下げ、血流の促進を通じて心臓血管全体の健康を促進することにより、高血圧の管理に貢献します。例えば、世界保健機関（WHO）は2023年3月、世界中で推定12億8,000万人の30～79歳の成人が高血圧症であり、その3分の2が低・中所得国に居住していると報告しました。したがって、高血圧症の有病率の上昇は、勃起不全治療薬市場の成長の原動力となっています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

• 高インフレが市場に与える影響
• ウクライナ・ロシア戦争が市場に与える影響
• COVID-19による市場への影響

第5章 世界市場規模と成長

• 世界の市場促進要因と抑制要因
  • 市場促進要因
  • 市場抑制要因
• 世界の市場規模実績と成長、2018年～2023年
• 世界の市場規模予測と成長、2023年～2028年、2033年

第6章 市場セグメンテーション

• 世界の勃起不全治療薬市場、薬剤別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• クエン酸シルデナフィル
• ミロデナフィル
• バルデナフィル
• 世界の勃起不全治療薬市場、投与方法別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 経口
• 外用
• 注射
• 世界の勃起不全治療薬市場、エンドユーザー別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 病院薬局
• 小売薬局
• オンライン薬局

第7章 地域および国の分析

• 世界の勃起不全治療薬市場、地域別、実績および予測、2018-2023年、2023-2028年、2033年
• 世界の勃起不全治療薬市場、国別、実績および予測、2018-2023年、2023-2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 勃起不全治療薬市場の競合情勢
• 勃起不全治療薬市場の企業プロファイル
  • Pfizer Inc.
  • Johnson &Johnson Services Inc.
  • Bayer AG
  • Sanofi SA
  • GlaxoSmithKline plc

第31章 その他の大手および革新的な企業

• Eli Lilly and Company
• Teva Pharmaceutical Industries Ltd.
• Boston Scientific Corporation
• Sun Pharmaceutical Industries Limited
• Coloplast A/S
• Cipla Limited
• Endo International plc
• Lupin Limited
• Glenmark Pharmaceuticals Limited
• SK Chemicals Co. Ltd.
• Dong A Pharmaceutical Co. Ltd.
• Zephyr Surgical Implants
• Seelos Therapeutics Inc.
• Premedon
• Meda Pharmaceuticals Inc.

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の見通しと可能性の分析

第36章 付録

Erectile dysfunction (ED) drugs are medications utilized to enhance the effects of nitric oxide, a naturally occurring substance in the body that relaxes penile muscles, aiming to address erectile dysfunction, which is the inability to achieve or maintain a penile erection in men.

Various types of ED drugs include sildenafil citrate, mirodenafil, and vardenafil. Sildenafil, available under trade names such as Viagra, is used to treat erectile dysfunction and pulmonary arterial hypertension. Its effectiveness in treating female genital dysfunction remains uncertain. These drugs can be administered orally, topically, or via injections, and are commonly distributed through hospital pharmacies, retail pharmacies, and online platforms.

The drugs for erectile dysfunction market research report is one of a series of new reports from The Business Research Company that provides drugs for erectile dysfunction market statistics, including drugs for erectile dysfunction industry global market size, regional shares, competitors with drugs for erectile dysfunction market share, detailed drugs for erectile dysfunction market segments, market trends and opportunities, and any further data you may need to thrive in the drugs for erectile dysfunction industry. This drugs for erectile dysfunction market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The drugs for erectile dysfunction market size has grown marginally in recent years. It will grow from $4.12 billion in 2023 to $4.17 billion in 2024 at a compound annual growth rate (CAGR) of 1.2%. The growth observed in the historic period can be attributed to several factors, including the introduction of PDE5 inhibitors (phosphodiesterase type 5 inhibitors), pharmaceutical marketing and advertising strategies, evolving societal attitudes towards erectile dysfunction (ED), an increase in cases of ED induced by lifestyle factors, and the availability of generic medications in the market.

The drugs for erectile dysfunction market size is expected to see marginal growth in the next few years. It will grow to $4.46 billion in 2028 at a compound annual growth rate (CAGR) of 1.7%. Forecasted growth is driven by mental health integration, changing consumer preferences, emerging market expansion, regenerative medicine exploration, and biopharmaceutical innovations. Major trends include novel therapy development, heightened awareness, lifestyle changes, telemedicine, and innovative delivery systems.

The significant rise in the number of chronic diseases is a key driver for the erectile dysfunction drug market. Erectile dysfunction is primarily linked to chronic conditions resulting from a sedentary lifestyle, such as cardiovascular diseases, diabetes, obesity, and high blood pressure. As reported by the World Health Organization (WHO) in September 2023, chronic diseases are responsible for 41 million deaths annually, accounting for 74% of all global deaths. The prevalence of chronic diseases heightens the likelihood of erectile dysfunction among men, consequently propelling the market for erectile dysfunction drugs.

The increasing prevalence of hypertension is anticipated to fuel the growth of the drugs for erectile dysfunction market in the foreseeable future. Hypertension, characterized by sustained high blood pressure against the artery walls, is a prevalent medical condition. Erectile dysfunction drugs, such as sildenafil, contribute to managing hypertension by improving blood vessel function, lowering blood pressure, and promoting overall cardiovascular health through enhanced blood flow. For instance, the World Health Organization (WHO) reported in March 2023 that an estimated 1.28 billion adults aged 30-79 years worldwide have hypertension, with two-thirds residing in low- and middle-income countries. Hence, the escalating prevalence of hypertension is a driving factor in the growth of the drugs for erectile dysfunction market.

Adverse effects linked to erectile dysfunction drugs have negatively impacted the market's growth during the forecast period. These side effects may contribute to decreased patient adherence and raise concerns among healthcare professionals, resulting in reduced adoption and trust in the medications, thereby impeding market expansion. A study conducted by RxList Inc., a US-based healthcare company, in July 2022, involving 511 men who experienced recurring side effects following Viagra consumption, highlighted common issues such as headaches, flushing, indigestion, and nasal congestion. Notably, 21% of patients experienced headaches, 19% experienced flushing, 9% experienced dyspepsia, and other side effects were reported, indicating potential challenges associated with drug side effects.

Several companies in the erectile dysfunction drugs market are implementing new drug delivery techniques, such as pellets and creams. These innovations offer increased efficacy, performance, and safety in treating erectile dysfunction. For example, in September 2022, Lupin, an India-based pharmaceutical company, launched Sildenafil for oral suspension, 10 mg/mL, approved by the United States Food and Drug Administration (FDA). This drug delivery method provides unique dosages for treating erectile dysfunction, enhancing treatment options and potentially addressing concerns related to side effects.

Major players in the drugs for erectile dysfunction market are strategically focusing on introducing combination capsules, such as therapy capsules, to optimize revenue. Tamsulosin and Tadalafil, a combination of medications targeting benign prostatic hyperplasia (BPH) and erectile dysfunction, is gaining prominence. In September 2023, Akums Drugs & Pharmaceuticals Ltd., an India-based pharmaceutical company, launched a therapy capsule addressing both conditions in the Indian market. This capsule, containing a combination of Tamsulosin and Tadalafil, demonstrates significant improvements in BPH and the Erectile Dysfunction Index. The introduction of such therapy capsules provides a novel treatment option for patients grappling with both conditions, catering to a broader spectrum of needs in the market.

Major companies operating in the drugs for erectile dysfunction market report are Pfizer Inc., Johnson & Johnson Services Inc., Bayer AG, Sanofi S.A., GlaxoSmithKline PLC, Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Boston Scientific Corporation, Sun Pharmaceutical Industries Limited, Coloplast A/S, Cipla Limited, Endo International PLC, Lupin Limited, Glenmark Pharmaceuticals Limited, S.K. Chemicals Co. Ltd., Dong A Pharmaceutical Co. Ltd., Zephyr Surgical Implants, Seelos Therapeutics Inc., Premedon, Meda Pharmaceuticals Inc., Futura Medical PLC, Augusta Medical Systems LLC, Vivus Inc., Apricus Biosciences Inc., Bonro Medical Inc., Cristalia Produtos Quimicos Farmaceuticos Ltda., Post-T-Vac Medical Inc., Adamed Pharma SA, Produtos Quimicos Farmaceuticos Ltda., Metuchen Pharmaceuticals LLC, Revive Pharmaceuticals Pvt. Ltd., Viatris Specialty LLC

North America was the largest region in the drugs for erectile dysfunction market in 2023. Middle East is expected to be the fastest-growing region in the global drugs for erectile dysfunction market during the forecast period. The regions covered in the drugs for erectile dysfunction market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the drugs for erectile dysfunction market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The erectile dysfunction (ED) drugs market consists of sales Sildenafil (Viagra), vardenafil (Levitra, Staxyn), tadalafil (Cialis) and avanafil (Stendra). Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Drugs For Erectile Dysfunction Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on drugs for erectile dysfunction market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for drugs for erectile dysfunction ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The drugs for erectile dysfunction market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

• 1) By Drugs: Sildenafil Citrate; Mirodenafil; Vardenafil
• 2) By Mode of Administration: Oral; Topical; Injections
• 3) By End users: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
• Companies Mentioned: Pfizer Inc.; Johnson & Johnson Services Inc.; Bayer AG; Sanofi S.A.; GlaxoSmithKline plc
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Drugs For Erectile Dysfunction Market Characteristics

3. Drugs For Erectile Dysfunction Market Trends And Strategies

4. Drugs For Erectile Dysfunction Market - Macro Economic Scenario

• 4.1. Impact Of High Inflation On The Market
• 4.2. Ukraine-Russia War Impact On The Market
• 4.3. COVID-19 Impact On The Market

5. Global Drugs For Erectile Dysfunction Market Size and Growth

• 5.1. Global Drugs For Erectile Dysfunction Market Drivers and Restraints
  • 5.1.1. Drivers Of The Market
  • 5.1.2. Restraints Of The Market
• 5.2. Global Drugs For Erectile Dysfunction Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
• 5.3. Global Drugs For Erectile Dysfunction Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Drugs For Erectile Dysfunction Market Segmentation

• 6.1. Global Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Sildenafil Citrate
• Mirodenafil
• Vardenafil
• 6.2. Global Drugs For Erectile Dysfunction Market, Segmentation By Mode of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Oral
• Topical
• Injections
• 6.3. Global Drugs For Erectile Dysfunction Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

7. Drugs For Erectile Dysfunction Market Regional And Country Analysis

• 7.1. Global Drugs For Erectile Dysfunction Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 7.2. Global Drugs For Erectile Dysfunction Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Drugs For Erectile Dysfunction Market

• 8.1. Asia-Pacific Drugs For Erectile Dysfunction Market Overview
• Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.3. Asia-Pacific Drugs For Erectile Dysfunction Market, Segmentation By Mode of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.4. Asia-Pacific Drugs For Erectile Dysfunction Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Drugs For Erectile Dysfunction Market

• 9.1. China Drugs For Erectile Dysfunction Market Overview
• 9.2. China Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.3. China Drugs For Erectile Dysfunction Market, Segmentation By Mode of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.4. China Drugs For Erectile Dysfunction Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Drugs For Erectile Dysfunction Market

• 10.1. India Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.2. India Drugs For Erectile Dysfunction Market, Segmentation By Mode of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.3. India Drugs For Erectile Dysfunction Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Drugs For Erectile Dysfunction Market

• 11.1. Japan Drugs For Erectile Dysfunction Market Overview
• 11.2. Japan Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.3. Japan Drugs For Erectile Dysfunction Market, Segmentation By Mode of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.4. Japan Drugs For Erectile Dysfunction Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Drugs For Erectile Dysfunction Market

• 12.1. Australia Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.2. Australia Drugs For Erectile Dysfunction Market, Segmentation By Mode of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.3. Australia Drugs For Erectile Dysfunction Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Drugs For Erectile Dysfunction Market

• 13.1. Indonesia Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.2. Indonesia Drugs For Erectile Dysfunction Market, Segmentation By Mode of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.3. Indonesia Drugs For Erectile Dysfunction Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Drugs For Erectile Dysfunction Market

• 14.1. South Korea Drugs For Erectile Dysfunction Market Overview
• 14.2. South Korea Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.3. South Korea Drugs For Erectile Dysfunction Market, Segmentation By Mode of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.4. South Korea Drugs For Erectile Dysfunction Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Drugs For Erectile Dysfunction Market

• 15.1. Western Europe Drugs For Erectile Dysfunction Market Overview
• 15.2. Western Europe Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.3. Western Europe Drugs For Erectile Dysfunction Market, Segmentation By Mode of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.4. Western Europe Drugs For Erectile Dysfunction Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Drugs For Erectile Dysfunction Market

• 16.1. UK Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.2. UK Drugs For Erectile Dysfunction Market, Segmentation By Mode of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.3. UK Drugs For Erectile Dysfunction Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Drugs For Erectile Dysfunction Market

• 17.1. Germany Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.2. Germany Drugs For Erectile Dysfunction Market, Segmentation By Mode of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.3. Germany Drugs For Erectile Dysfunction Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Drugs For Erectile Dysfunction Market

• 18.1. France Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.2. France Drugs For Erectile Dysfunction Market, Segmentation By Mode of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.3. France Drugs For Erectile Dysfunction Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Drugs For Erectile Dysfunction Market

• 19.1. Italy Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.2. Italy Drugs For Erectile Dysfunction Market, Segmentation By Mode of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.3. Italy Drugs For Erectile Dysfunction Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Drugs For Erectile Dysfunction Market

• 20.1. Spain Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.2. Spain Drugs For Erectile Dysfunction Market, Segmentation By Mode of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.3. Spain Drugs For Erectile Dysfunction Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Drugs For Erectile Dysfunction Market

• 21.1. Eastern Europe Drugs For Erectile Dysfunction Market Overview
• 21.2. Eastern Europe Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.3. Eastern Europe Drugs For Erectile Dysfunction Market, Segmentation By Mode of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.4. Eastern Europe Drugs For Erectile Dysfunction Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Drugs For Erectile Dysfunction Market

• 22.1. Russia Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.2. Russia Drugs For Erectile Dysfunction Market, Segmentation By Mode of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.3. Russia Drugs For Erectile Dysfunction Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Drugs For Erectile Dysfunction Market

• 23.1. North America Drugs For Erectile Dysfunction Market Overview
• 23.2. North America Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.3. North America Drugs For Erectile Dysfunction Market, Segmentation By Mode of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.4. North America Drugs For Erectile Dysfunction Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Drugs For Erectile Dysfunction Market

• 24.1. USA Drugs For Erectile Dysfunction Market Overview
• 24.2. USA Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.3. USA Drugs For Erectile Dysfunction Market, Segmentation By Mode of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.4. USA Drugs For Erectile Dysfunction Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Drugs For Erectile Dysfunction Market

• 25.1. Canada Drugs For Erectile Dysfunction Market Overview
• 25.2. Canada Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.3. Canada Drugs For Erectile Dysfunction Market, Segmentation By Mode of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.4. Canada Drugs For Erectile Dysfunction Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Drugs For Erectile Dysfunction Market

• 26.1. South America Drugs For Erectile Dysfunction Market Overview
• 26.2. South America Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.3. South America Drugs For Erectile Dysfunction Market, Segmentation By Mode of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.4. South America Drugs For Erectile Dysfunction Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Drugs For Erectile Dysfunction Market

• 27.1. Brazil Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.2. Brazil Drugs For Erectile Dysfunction Market, Segmentation By Mode of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.3. Brazil Drugs For Erectile Dysfunction Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Drugs For Erectile Dysfunction Market

• 28.1. Middle East Drugs For Erectile Dysfunction Market Overview
• 28.2. Middle East Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.3. Middle East Drugs For Erectile Dysfunction Market, Segmentation By Mode of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.4. Middle East Drugs For Erectile Dysfunction Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Drugs For Erectile Dysfunction Market

• 29.1. Africa Drugs For Erectile Dysfunction Market Overview
• 29.2. Africa Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.3. Africa Drugs For Erectile Dysfunction Market, Segmentation By Mode of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.4. Africa Drugs For Erectile Dysfunction Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Drugs For Erectile Dysfunction Market Competitive Landscape And Company Profiles

• 30.1. Drugs For Erectile Dysfunction Market Competitive Landscape
• 30.2. Drugs For Erectile Dysfunction Market Company Profiles
  • 30.2.1. Pfizer Inc.
    • 30.2.1.1. Overview
    • 30.2.1.2. Products and Services
    • 30.2.1.3. Strategy
    • 30.2.1.4. Financial Performance
  • 30.2.2. Johnson & Johnson Services Inc.
    • 30.2.2.1. Overview
    • 30.2.2.2. Products and Services
    • 30.2.2.3. Strategy
    • 30.2.2.4. Financial Performance
  • 30.2.3. Bayer AG
    • 30.2.3.1. Overview
    • 30.2.3.2. Products and Services
    • 30.2.3.3. Strategy
    • 30.2.3.4. Financial Performance
  • 30.2.4. Sanofi S.A.
    • 30.2.4.1. Overview
    • 30.2.4.2. Products and Services
    • 30.2.4.3. Strategy
    • 30.2.4.4. Financial Performance
  • 30.2.5. GlaxoSmithKline plc
    • 30.2.5.1. Overview
    • 30.2.5.2. Products and Services
    • 30.2.5.3. Strategy
    • 30.2.5.4. Financial Performance

31. Drugs For Erectile Dysfunction Market Other Major And Innovative Companies

• 31.1. Eli Lilly and Company
• 31.2. Teva Pharmaceutical Industries Ltd.
• 31.3. Boston Scientific Corporation
• 31.4. Sun Pharmaceutical Industries Limited
• 31.5. Coloplast A/S
• 31.6. Cipla Limited
• 31.7. Endo International plc
• 31.8. Lupin Limited
• 31.9. Glenmark Pharmaceuticals Limited
• 31.10. S.K. Chemicals Co. Ltd.
• 31.11. Dong A Pharmaceutical Co. Ltd.
• 31.12. Zephyr Surgical Implants
• 31.13. Seelos Therapeutics Inc.
• 31.14. Premedon
• 31.15. Meda Pharmaceuticals Inc.

32. Global Drugs For Erectile Dysfunction Market Competitive Benchmarking

33. Global Drugs For Erectile Dysfunction Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Drugs For Erectile Dysfunction Market

35. Drugs For Erectile Dysfunction Market Future Outlook and Potential Analysis

• 35.1 Drugs For Erectile Dysfunction Market In 2028 - Countries Offering Most New Opportunities
• 35.2 Drugs For Erectile Dysfunction Market In 2028 - Segments Offering Most New Opportunities
• 35.3 Drugs For Erectile Dysfunction Market In 2028 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer